Avnet (AVT) Preliminary Q1 Results Miss Views
Tweet
Share
E-mailGet Alerts AVT Hot Sheet
Price: $95.71 -0.29%
Financial Fact:
Other income (expense), net: -13.73M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Other income (expense), net: -13.73M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Avnet, Inc. (NYSE: AVT) reported that its sales for the first quarter of fiscal 2013 ended September 29, 2012 will be approximately $5.85 billion, roughly 9% below the year-ago quarter and towards the lower end of original expectations.
The Street sees $6.07 billion.
Sales at Electronics Marketing (EM) and Technology Solutions (TS) for the September quarter are expected to be approximately $3.65 billion and $2.20 billion, respectively. The Company also indicated that its diluted earnings per share, excluding restructuring, integration and other charges, is expected to be between $0.52 and $0.58, below its previously announced expectations.
The Street sees EPS of $0.83.
The revised estimated earnings per share for the September 2012 quarter is primarily attributable to the combined negative impacts of (1) lower than expected revenues, most notably at TS, (2) lower gross profit margin in the Western regions at EM associated with the weaker sales environment and (3) a greater than anticipated geographic mix shift in the EM business where better than expected sales in the lower-margin Asia region were more than offset by weaker sales in the higher-margin Western regions.
The Street sees $6.07 billion.
Sales at Electronics Marketing (EM) and Technology Solutions (TS) for the September quarter are expected to be approximately $3.65 billion and $2.20 billion, respectively. The Company also indicated that its diluted earnings per share, excluding restructuring, integration and other charges, is expected to be between $0.52 and $0.58, below its previously announced expectations.
The Street sees EPS of $0.83.
The revised estimated earnings per share for the September 2012 quarter is primarily attributable to the combined negative impacts of (1) lower than expected revenues, most notably at TS, (2) lower gross profit margin in the Western regions at EM associated with the weaker sales environment and (3) a greater than anticipated geographic mix shift in the EM business where better than expected sales in the lower-margin Asia region were more than offset by weaker sales in the higher-margin Western regions.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
- Vivos Therapeutics posts 35% revenue gain but widens net loss
Create E-mail Alert Related Categories
Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
